ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,390Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 783

$620K Total Retail Price of All Prescriptions

Rank: 189 out of 783

437 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 11,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 541 416 S3 1 2
LEVOTHYROXINE SODIUM 457 428 2 1
LISINOPRIL 386 359 3 4
FUROSEMIDE 365 327 4 7
OMEPRAZOLE 355 298 5 6
SIMVASTATIN 324 287 6 3
AMLODIPINE BESYLATE 303 282 7 5
WARFARIN SODIUM 287 280 8 10
POTASSIUM CHLORIDE 235 214 9 16
PRAVASTATIN SODIUM 222 204 10 14
MELOXICAM 200 192 11 37
METOPROLOL SUCCINATE 195 177 12 13
HYDROCHLOROTHIAZIDE 173 160 13 12
AZITHROMYCIN 158 130 14 41
CITALOPRAM HBR 153 117 15 19
LOSARTAN POTASSIUM 150 149 16 18
METOPROLOL TARTRATE 144 130 17 9
METFORMIN HCL 134 123 18 8
GABAPENTIN 131 112 19 15
ATENOLOL 128 126 20 17
ATORVASTATIN CALCIUM 106 104 21 11
PREDNISONE 105 100 22 36
DIOVAN 102 97 23 49
ALLOPURINOL 102 90 23 31
CYMBALTA 99 79 25 35
CLOPIDOGREL 99 95 25 29
TRAMADOL HCL 97 93 27 20
ENALAPRIL MALEATE 97 69 27 68
SINGULAIR 92 77 29 90
CIPROFLOXACIN HCL 86 84 30 62
AMITRIPTYLINE HCL 86 86 R 30 77
ESCITALOPRAM OXALATE 82 82 32 54
CARVEDILOL 82 81 32 21
NAMENDA 81 81 34 32
CYCLOBENZAPRINE HCL 75 56 R 35 63
LEVOFLOXACIN 75 48 35 75
KLOR-CON M20 74 74 37 48
DIOVAN HCT 72 63 38 94
ZOLPIDEM TARTRATE 72 50 38 23
PLAVIX 71 71 40 51
NEXIUM 71 63 40 28
LOSARTAN-HYDROCHLOROTHIAZIDE 70 70 42 53
MECLIZINE HCL 68 67 43 146
METHOCARBAMOL 68 67 R 43 215
MONTELUKAST SODIUM 66 57 45 160
HYDRALAZINE HCL 66 66 45 78
CLONIDINE HCL 66 49 45 60
LEVETIRACETAM 65 54 48 89
SERTRALINE HCL 65 65 48 22
TAMSULOSIN HCL 64 57 50 26
ESTRADIOL 62 40 R 51 204
DILTIAZEM 24HR CD 62 62 51 118
FENOFIBRATE 61 57 53 66
PANTOPRAZOLE SODIUM 61 51 53 30
BYSTOLIC 59 59 55 99
CRESTOR 59 59 55 27
ADVAIR DISKUS 58 58 57 50
CEPHALEXIN 56 55 58 70
GLIMEPIRIDE 54 44 59 34
LUNESTA 54 54 59 290
TRAMADOL HCL-ACETAMINOPHEN 53 49 61 167
GLIPIZIDE 51 40 62 71
BACLOFEN 51 48 62 125
RANITIDINE HCL 50 38 64 44
LYRICA 50 37 64 98
ACETAMINOPHEN-CODEINE 50 50 S3 64 144
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.